Related Experiment Video
Updated: Apr 10, 2026

07:47
Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
Published on: December 25, 2021
4.7K
Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness
Gisela Caceres1, John A Puskas, Anthony M Magliocco
1Department of Anatomic Pathology, Moffitt Cancer Center, Tampa, FL 33612, USA. Anthony.Magliocco@Moffitt.org.
Cancer Control : Journal of the Moffitt Cancer Center
|June 13, 2015
Summary
Circulating tumor cells (CTCs) offer real-time cancer monitoring via liquid biopsies. Advanced techniques are making CTC analysis a reality for understanding tumor behavior and improving treatment.
Area of Science:
- Oncology
- Biotechnology
- Cancer Research
Background:
- Circulating tumor cells (CTCs) are crucial biomarkers for understanding cancer metastasis and progression.
- CTCs provide insights into tumor development and patient prognosis.
Purpose of the Study:
- To review the significance, limitations, and clinical applications of CTCs in cancer management.
- To explore how CTC analysis can inform treatment efficacy and monitor therapeutic responses.
Main Methods:
- Review of current literature on CTC detection and characterization.
- Discussion of challenges in identifying rare CTCs due to limited unique surface markers.
- Highlighting the role of novel techniques, such as microfluidics, in CTC isolation and analysis.
Main Results:
- Liquid biopsy analysis of CTCs enables real-time monitoring of cancer progression.
- Quantifying CTCs aids in assessing treatment efficacy and predicting metastatic potential.
- Emerging technologies are improving the ability to isolate and analyze CTCs.
Conclusions:
- CTCs hold significant promise as a non-invasive tool for personalized cancer therapy.
- Innovative techniques are overcoming challenges in CTC characterization.
- Further research into CTCs can lead to better cancer diagnostics and treatments.
Related Concept Videos
Metastasis
6.9K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.9K
The Tumor Microenvironment
8.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.2K

